Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development of Clinical Scale Cytomegalovirus-Specific T Cells for Adoptive Immunotherapy Using pp65.

Paraskevi Diamanti, PhD, Russell J. Garland, PhD, Derwood H. Pamphilon, MD, Colin G. Steward, MD, PhD, Allison Blair, PhD

Blood (2005) 106 (11): 5250.

https://doi.org/10.1182/blood.V106.11.5250.5250

Published: 2005

Journal Articles

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Russell J. Garland, PhD, Paraskevi Diamanti, PhD, Samantha E. West, PhD, Ann Green, MSc, David Carrington, PhD, Sarah J. Groves, BSc, Kerri L. Winship, BSc, Stephen P. Robinson, MD, Anthony Oakhill, MD, Jacqueline M. Cornish, MD, Derwood H. Pamphilon, MD, David I. Marks, MD, Nicholas J. Goulden, MD, Allison G. Blair, PhD, Colin G. Steward, MD

Blood (2004) 104 (11): 2244.

https://doi.org/10.1182/blood.V104.11.2244.2244

Published: 2004

Journal Articles

Characterization of acute lymphoblastic leukemia progenitor cells

Charlotte V. Cox, Roger S. Evely, Anthony Oakhill, Derwood H. Pamphilon, Nicholas J. Goulden, Allison Blair

Blood (2004) 104 (9): 2919–2925.

https://doi.org/10.1182/blood-2004-03-0901

Published: 2004

Journal Articles

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Ann Green, Emer Clarke, Linda Hunt, Andrew Canterbury, Alan Lankester, Geoff Hale, Herman Waldmann, Sally Goodman, Jacqueline M. Cornish, David I. Marks, Colin G. Steward, Anthony Oakhill, Derwood H. Pamphilon

Blood (1999) 94 (7): 2236–2246.

https://doi.org/10.1182/blood.V94.7.2236.419k04_2236_2246

Published: 1999

Journal Articles

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Christopher J.C. Knechtli, Nicholas J. Goulden, Jeremy P. Hancock, Victoria L.G. Grandage, Emma L. Harris, Russell J. Garland, Claire G. Jones, Anthony W. Rowbottom, Linda P. Hunt, Ann F. Green, Emer Clarke, Alan W. Lankester, Jacqueline M. Cornish, Derwood H. Pamphilon, Colin G. Steward, Anthony Oakhill

Blood (1998) 92 (11): 4072–4079.

https://doi.org/10.1182/blood.V92.11.4072

Published: 1998

NARROW

Development of Clinical Scale Cytomegalovirus-Specific T Cells for Adoptive Immunotherapy Using pp65.

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Characterization of acute lymphoblastic leukemia progenitor cells

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Development of Clinical Scale Cytomegalovirus-Specific T Cells for Adoptive Immunotherapy Using pp65.

CMV Specific Immunotherapy: How Many Patients Will Benefit?.

Characterization of acute lymphoblastic leukemia progenitor cells

Children With Acute Lymphoblastic Leukemia Who Receive T-Cell–Depleted HLA Mismatched Marrow Allografts From Unrelated Donors Have an Increased Incidence of Primary Graft Failure but a Similar Overall Transplant Outcome

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only